Calcified Tissue International

, Volume 33, Issue 1, pp 285–286 | Cite as

Effect of sodium etidronate and phenytoin on pagetic bone

  • H. M. PerryIII
  • Louis V. Avioli


Sodium Etidronate Pagetic Bone Sodium Etidronate 


  1. 1.
    Hahn, T. J., Hendin, B. A., Scharp, C. R., Boisseau, V. C., Haddad, J. G.: Serum 25-hydroxycalciferol levels and bone mass in children on chronic anticonvulsant therapy, N. Engl. J. Med.292:550–554, 1975CrossRefGoogle Scholar
  2. 2.
    Hill, L. F., Lumb, G. A., Mawer, E. B., Stanbury, S. W.: Indirect inhibition of the biosynthesis of 1,25 dihydroxycholecalciferol in rats treated with a diphosphonate, Clin. Sci.44, 335–347, 1973PubMedGoogle Scholar
  3. 3.
    Khairi, M. R. A., Altman, R. D., DeRosa, G. P., Zimmermann, J., Schenk, R. K., Johnston, C. C.: Sodium etidronate in the treatment of Paget's disease of bone, Ann. Intern. Med.87:656–663, 1977PubMedGoogle Scholar
  4. 4.
    DeRose, J., Singer, F. R., Avramides, A., Flores, A., Dziadiw, R., Baker, R. K., Wallach, S.: Response of Paget's disease to porcine and salmon calcitonins, Am. J. Med.56:858–866, 1974CrossRefPubMedGoogle Scholar
  5. 5.
    Plasmans, C. M. T., Jap, P. H. K., Kuijpers, W., Slooff, T. J. J. H.: Influence of a diphosphonate on the cellular aspect of young bone tissue, Calcif. Tissue Int.32, 247–256, 1980PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1981

Authors and Affiliations

  • H. M. PerryIII
    • 1
  • Louis V. Avioli
    • 1
  1. 1.Washington University of Medicine, The Jewish Hospital of St. LouisSt. LouisUSA

Personalised recommendations